Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.75	4.61	56.41	84.83	114.2	8.79
Short-Term Investments	71.44	46.49	-	-	-	-
Cash & Short-Term Investments	78.19	51.1	56.41	84.83	114.2	8.79
Cash Growth	31.17%	-9.41%	-33.51%	-25.71%	1199.00%	-32.23%
Other Receivables	-	-	-	-	0.11	0.25
Receivables	-	-	-	-	0.11	0.25
Prepaid Expenses	2.88	4.94	3.08	3.48	1.29	0.88
Other Current Assets	0.44	0.09	0.03	0.03	0.04	0.05
Total Current Assets	81.51	56.13	59.52	88.35	115.63	9.97
Property, Plant & Equipment	0.47	0.37	0.74	0.77	0.14	0.32
Goodwill	-	-	-	48.65	48.65	-
Other Intangible Assets	32.39	32.39	32.39	32.39	32.39	-
Other Long-Term Assets	0.21	0.19	0.15	0.4	0.38	0.64
Total Assets	114.58	89.07	92.79	170.55	197.19	10.93
Accounts Payable	5.86	0.97	2.2	1.81	1.37	0.33
Accrued Expenses	6.44	2.55	3.91	2.22	0.97	0.81
Current Portion of Leases	0.19	0.38	0.36	0.37	0.14	0.18
Total Current Liabilities	12.49	3.9	6.48	4.4	2.48	1.32
Long-Term Leases	0.32	-	0.38	0.4	-	0.14
Long-Term Deferred Tax Liabilities	1.75	1.75	1.75	1.75	4.11	-
Other Long-Term Liabilities	23.96	76.21	-	-	-	-
Total Liabilities	38.52	81.86	8.61	6.55	6.59	1.47
Common Stock	0.04	0.02	0.01	0.01	0.02	0
Additional Paid-In Capital	386.88	326.59	287.03	278.88	270.97	67.05
Retained Earnings	-310.97	-319.4	-202.87	-114.9	-80.39	-57.58
Total Common Equity	76.06	7.21	84.18	164	190.6	9.47
Shareholders' Equity	76.06	7.21	84.18	164	190.6	9.47
Total Liabilities & Equity	114.58	89.07	92.79	170.55	197.19	10.93
Total Debt	0.5	0.38	0.75	0.77	0.14	0.32
Net Cash (Debt)	77.69	50.72	55.66	84.06	114.05	8.47
Net Cash Growth	31.39%	-8.88%	-33.78%	-26.29%	1247.01%	-34.73%
Net Cash Per Share	2.01	2.06	3.90	5.67	78.58	12.92
Filing Date Shares Outstanding	59.74	24.21	13.78	14.31	14.31	0.89
Total Common Shares Outstanding	41.18	24.21	13.78	14.31	15.16	0.72
Working Capital	69.02	52.23	53.04	83.95	113.15	8.65
Book Value Per Share	1.85	0.30	6.11	11.46	12.57	13.14
Tangible Book Value	43.67	-25.18	51.8	82.96	109.56	9.47
Tangible Book Value Per Share	1.06	-1.04	3.76	5.80	7.23	13.14

Source: S&P Capital IQ. Standard template. Financial Sources.